Alpha Tau Medical focuses on research, development, and commercialization of Diffusing Alpha-Emitters Radiation Therapy, a new type of brachytherapy for the treatment of solid cancer tumors. By using alpha radiation rather than the commonly used beta or gamma radiation, Alpha Tau Medical’s therapy is more effective than standard brachytherapy methods with less radiation, adverse effects and toxicities. The company is initially focusing on the treatment of head and neck cancer as well as skin and oral cavity cancer and it is currently conducting clinical studies to expand the treatment to additional types of cancer.